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Methyl 2-acetamido-3-O-benzoyl-4-O-benzyl-2-deoxy-α-D-glucopyranoside (14)
Compound 24 [S3] (175 mg, 0.54 mmol) was dissolved in dry pyridine (3.5 mL) and treated with benzoyl chloride (187 µL, 1.62 mmol) at 0 °C. After stirring for 16 h at ambient temperature excessive reagent was destroyed by slow addition of dry MeOH (2 mL, at 0 °C). The mixture was coevaporated with toluene (2x) and the residue was purified by chromatography (toluene/EtOAc 1:1) yielding 26 [S5] (165 mg, 71%). A solution of compound 26 (61 mg, 0.143 mmol) in dry CH 2 Cl 2 (3.0 mL) containing 4 Å ground molecular sieves (150 mg) was stirred at ambient temperature for 1 h. To the cooled (-78 °C) mixture triethylsilane (114 µL, 0.714 mmol) and dichlorophenylborane (93 µL, 0.714 mmol) were added dropwise. [S6] After 30 min triethylamine (0.35 mL) and dry MeOH (0.35 mL) were added consecutively. The mixture was partitioned between chloroform and satd. NaHCO 3 , the aqueous phase was further extracted (2x) with chloroform. The combined organic phases were dried (MgSO 4 ), filtered and the filtrate was concentrated. The residue was purified by two consecutive chromatographic separations (EtOAc:EtOH 9:1, then CHCl 3 :MeOH 100:2) which gave acceptor 14 (43 mg, 70%); the analytical data was in agreement with published data.
[S7] A solution of allyl 2-deoxy-2-phthalimido-β-glucopyranoside (140 mg, 0.40 mmol), benzaldehyde dimethyl acetal (72 µL 0.48 mmol) and p-toluenesulfonic acid monohydrate (4 mg, 0.024 mmol) in dry acetonitrile (6.0 mL) was stirred at ambient temperature for 1 h. After addition of triethylamine (12 µL) the volatile components were removed in vacuo and the residue was purified by chromatography (toluene/EtOAc 40:1 →7:1) affording 27 [S8] (162 mg, 92%): A solution of compound 27 (346 mg, 0.79 mmol) in dry DMF (10.0 mL) was treated with sodium hydride (60% in mineral oil, 63 mg, 1.58 mmol) portionwise and was stirred for 30 min after complete addition. Next, benzyl bromide (376 µL, 3.16 mmol) was added and stirring was continued for and 1 h at room temperature. Excessive reagent was destroyed by addition of dry MeOH (2 mL). The mixture was partitioned between satd. ammonium chloride and diethyl ether and the aqueous phase was extracted with diethyl ether twice. The combined organic layers were dried (MgSO 4 ), filtered and concentrated. The residue was purified by chromatography (toluene/EtOAc 20:1) providing 28 [S9] (dd, 1H, J 6a,6b 10.1, J 6a,5 4.6 Hz, H-6a), 4.28 -4.23 (m, 2H, H-2, CHH-CH=CH 2 ), 4.02 -3.98 (m, 1H, CHH-CH=CH 2 ), 3.87 (app t, 1H, J 6b,5 ~ 9.8 Hz, H-6b), 3.83 (app t, 1H, J 4,5 ~ 9.3 Hz, H-4) and 3.65 ppm (app td, 1H, H-5).
Allyl 3-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranoside (8)
O
S-4
Compound 28 (290 mg, 0.55 mmol) was dissolved in 80% AcOH (10 mL) and heated to 60 °C for 2.5 h. The mixture was concentrated and purified by chromatography (toluene/EtOAc 1:1) yielding 8 [S10] (230 mg, A suspension of glycosyl acceptor 2 (28.3 mg, 0.087 mmol) and 3-iodo donor 1 (52.5 mg, 0.096 mmol) in dry CH 2 Cl 2 (4.0 mL) containing ground 3 Å molecular sieves (200 mg) was stirred at ambient temperature for 2h. BF 3 •Et 2 O (35.7 μL, 0.278 mmol) was added at 0 °C and the mixture kept at ambient temperature for 90 min. After addition of satd. aq. NaHCO 3 and CH 2 Cl 2 , the mixture was extracted, the aqueous phase once again treated with CH 2 Cl 2 and the combined organic layers were washed successively with sodium thiosulfate (5 w%) and brine. The organic layer was dried (MgSO 4 ), filtered and concentrated. The crude product was purified by chromatography (toluene/EtOAc 2:10:1) affording a mixture of several disaccharide compounds, which were further separated by HPchromatography (EtOAc) which afforded disaccharide 3 (23.5 mg, 32%), furano-oxazoline 4 (7.6 mg, 11%) and pyrano-oxazoline 5 (2.1 mg, 3 %) as colourless oils. CH 2 Ph), 73.9 (d, C-5), 71.4 (d, C-4), 68.1 (d, C-6'), 67.7 (d, C-7'), 65.5 (t, C-6), 65.4 (d, C-4'), 63.3 (d, C-5'), 62.0 (t, C-8'), 57.1 (d, C-2), 56.9 (q, OCH 3 ), 53.1 (q, CO 2 CH 3 ), 23.6 (q, COCH 3 ), 21.9 (d, C-3'), 20.90, 20.86, 20.7 and 20.6 A solution of donor 1 (40 mg, 0.074 mmol) in dry CH 2 Cl 2 (3.0 mL) was added to acceptor 10 (20 mg, 0.061 mmol) and the suspension was stirred at ambient temperature for 1 h in the presence of 3 Å ground molecular sieves (150 mg). BF 3• Et 2 O (23 µL, 0.184 mmol) was added at 0 °C. After 1 h at room temperature satd. aq. NaHCO 3 solution was added and the mixture was repeatedly extracted with 23.4, 21.9, 20.9, 20.81, 20 .75 and 20.6 ppm (5 q, 1 d, 6C, 5 x COCH 3 , C-3'); LC-MS [S11] : m/z found: 
Methyl (4,5,7,8-tetra-O-acetyl-3-deoxy-3-iodo-D-glycero-α-D-talo-oct-2-ulopyranosyl)onate-(26)-methyl 2-acetamido-3-O-benzyl-2-deoxy-α-D-glucopyranoside (11)
Os, C-2'), 98.6 (d, C-1), 80.5 (d, C-3), 74.0 (t, CH 2 Ph), 70.7 (d, C-4), 70.1 (d, C-5), 68.3 (d, C-6'), 67.9 (d, C-7'), 65.5 (t, C-6), 65.3 (d, C-4'), 63.4 (d, C-5'), 62.0 (t, C-8'), 55.1 (q, OCH 3 ), 53.1 (q, CO 2 CH 3 ), 51.9 (d, C-2),
12
A solution of compound 11 in dry pyridine (3 mL) was treated with 4-(N,N-dimethylamino)pyridine (1 mg) and acetic anhydride (0.3 mL) for 5 h at room temperature. The mixture was cooled (0 °C) and dry MeOH (1 mL) was added slowly. After 5 min the mixture was coevaporated with toluene (3 x) and the residue was purified by chromatography (toluene/EtOAc 1:3) followed by HPLC (toluene/EtOAc 1:2) which afforded disaccharide 12 (13 mg, 59%) as a colorless oil: R f 0.30 (CH 2 Cl 2 /EtOAc 1:1, HP-TLC); 
S-8 7'), 65.2 (d, C-4'), 64.9 (t, C-6), 63.5 (d, C-5'), 61.8 (t, C-8'), 55.3 (d, OCH 3 ), 52.9 (q, CO 2 CH 3 ), 51.9 (d, C-2), 23.3, 22.0, 20.89, 20.86, 20.8, 20.7 and 20 .6 ppm (6 q, 1 d, 7C, 6 x COCH 3 , C-3'); LC-MS [S11] : m/z found: 896. Compound 12 (12.0 mg, 0.013 mmol) was suspended in dry cyclohexane (4.0 mL) and dry 1,2-dichloroethane (0.5 mL). After degassing with argon the mixture was refluxed for 15 min followed by addition of lauroyl peroxide (1.9 mg, 0.005 mmol). Refluxing for 2 h and solvent evaporation afforded a crude product which was separated by chromatography (toluene/EtOAc 1:4 → 0.1) and HPLC (EtOAc) providing disaccharide 13 (7.7 mg, 75%) as a colorless oil: R f 0.28 (CH 2 Cl 2 /EtOAc 1:1, HP-TLC); The 3-iodo donor 1 (10 mg, 0.018 mmol) was dissolved in dry CDCl 3 (kept over 4 Å molecular sieves overnight) in an NMR tube and 2-propanol (2.8 µL, 0.036 mmol ) and the respective olefin (~ 2 eq., see immediately. In the presence of 1-octene (entry I) and cyclohexene (entry II) complete consumption of donor 1 was already detected in the first spectrum (reaction time: < 1min). For allyl methyl ether (entry III) 1 H spectra were collected over a period of 1 h with variable time intervals in between. The integrals of representative signals for donor 1, glycal ester 6 and glycoside 9 were collected in relation to the residual solvent peak. The integral of the donor signal in the reference spectrum was defined as 100%, the percentages of the collected integral values were calculated and plotted over time in a diagram (see Fig. S14 ). For methyl crotonate (entry IV) no effect of the olefin on the glycosylation was observed. To perform a negative control, the same procedure was repeated in the absence of donor 1 (for entries I to III). The 1 H-NMR spectra were collected before and after BF 3 .Et 2 O addition (see below). In all cases the signals of 2-propanol were significantly shifted, the olefin signals remained unchanged or were slightly shifted, respectively. However, no degradation or consumption of the respective olefin was observed. 
Methyl (4,5,7,8-tetra-O-acetyl-3-deoxy-α-D-manno-oct-2-ulopyranosyl)onate-(26)-methyl 2-acetamido-4-O-acetyl-3-O-benzyl-2-deoxy-α-D-glucopyranoside (13)
1-Octene (entry I)
Fig. S14:
The decrease of donor 1 correlates with the parallel formation of glycal ester 6 and glycoside 9. This shows, that both pathways are active. The total amount of glycal 6 and glycoside 9 did not reach 100% due to some residual donor (~ 4%) and formation of hydrolysed donor. 
